Abstract

Withdrawal from binge-drinking increases negative affect, coinciding with increased expression of the metabotropic glutamate receptor 5 (mGlu5) within the shell of the nucleus accumbens (AcbSh). Supporting a causal-effect relationship, systemic treatment with the mGlu5 receptor antagonist MTEP [3-((2-Methyl-4-thiazolyl)ethynyl)pyridine] is anxiolytic in binge-drinking adult and adolescent mice. Here, we employed neuropharmacological approaches to examine the functional relevance of AcbSh mGlu5 for behavioral indices of alcohol withdrawal-induced hyper-anxiety. Adult (PND 56) and adolescent (PND 28) male C57BL/6J mice consumed alcohol under modified Drinking-in-the-Dark procedures (10, 20, and 40% alcohol v/v) for 14 days. At an alcohol withdrawal time-point when mice manifest robust behavioral signs of hyper-anxiety (1 and 28 days withdrawal for adults and adolescents, respectively), mice were infused intra-AcbSh with 0, 1 or 10 μg MTEP and then affect was assayed in the light-dark shuttle box, marble-burying and forced swim tests. Brain tissue was collected to evaluate changes in Egr1 (early growth response protein 1) induction to index AcbSh neuronal activity. As expected, alcohol-experienced mice exhibited behavioral signs of hyper-emotionality. The anxiolytic effects of intra-AchSh MTEP were modest, but dose-dependent, and varied with age of drinking-onset. In adult-onset mice, only the 1 μg MTEP dose reduced withdrawal-induced hyper-anxiety, whereas only the higher dose was effective in adolescent-onset animals. MTEP reduced Egr1 expression within the AcbSh, irrespective of alcohol drinking history or age of drinking-onset. However, only the high MTEP dose reduced Egr1 expression in adolescent-onset binging mice. These results implicate AcbSh mGlu5 in modulating alcohol withdrawal-induced negative affect and suggest age differences in the neurobiological effects of alcohol withdrawal and behavioral responsiveness to mGlu5 blockade within the AcbSh.

Highlights

  • Binge-drinking is defined as a pattern of consumption that elevates blood alcohol concentrations (BAC) to ≥80 mg/dl, which equates to approximately 4–5 drinks in a 2-h period (National Institute on Alcohol Abuse Alcoholism [NIAAA], 2004)

  • On day 11 of drinking, adults consumed an average of 3.69 ± 0.31 g/kg resulting in an average BAC of 69.93 ± 3.17 mg/dl and adolescents consumed an average of 4.94 ± 0.34 g/kg resulting in an average BAC of 78.29 ± 3.01 mg/dl

  • The accumbens shell (AcbSh) is a component of the emotional circuitry of the extended amygdala, relatively little is known regarding the role of the AcbSh in negative affective states during drug withdrawal

Read more

Summary

Introduction

Binge-drinking is defined as a pattern of consumption that elevates blood alcohol concentrations (BAC) to ≥80 mg/dl, which equates to approximately 4–5 drinks in a 2-h period (National Institute on Alcohol Abuse Alcoholism [NIAAA], 2004) In both humans and laboratory animal models, a history of binge alcoholdrinking augments symptoms of negative affect and dysphoria during periods of abstinence (e.g., Hasin and Grant, 2002; Grant et al, 2004; Squeglia et al, 2009; Lee et al, 2015, 2016, 2017a,b, 2018) and this withdrawal-induced negative affect is theorized to drive the negative reinforcing properties of alcohol (Becker, 2012; Tunstall et al, 2017). These latter findings are in-line with the epidemiological literature demonstrating latent and enduring emotional disturbances in individuals with a history of problem drinking during adolescence (e.g., Hasin and Grant, 2002; Grant et al, 2004; Hasin et al, 2007; Squeglia et al, 2009) and argue that binge-drinking during adolescence perturbs the development of neural circuits controlling emotionality

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call